A Study of a 2-dose Ebola Vaccine Regimen of Ad26.ZEBOV Followed by MVA-BN-Filo in Healthy Pregnant Women

NCT04556526 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
4031
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Janssen Vaccines & Prevention B.V.

Collaborators